Has Jacqueline Walter received payments from drug or device companies?

Yes. Drug and device makers reported $2,155 in general payments to Jacqueline Walter across 101 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jacqueline Walter did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jacqueline Walter come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jacqueline Walter

Pediatrics · Bogalusa, LANPI 1225414063

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 30.5% of the total. Reporting peaked in 2023 at $648 and has fallen 61.7% since, to $248 in 2025. Among pediatrics clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,155in general payments, 2019–2025

Across 101 payments — averaging $21.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Supernus Pharmaceuticals, Inc.$657
Tris Pharma Inc$266
GSK$238
Noven Therapeutics, LLC$179
Sanofi$177
Sanofi-aventis U.S. LLC$110
plus $529 from 11 others

What the payments were for

Food & beverage$2,155100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Supernus Pharmaceuticals, Inc.	40	$657
Tris Pharma Inc	11	$266
GSK	8	$238
Noven Therapeutics, LLC	10	$179
Sanofi	1	$177
Sanofi-aventis U.S. LLC	2	$110
Ironshore Pharmaceuticals Inc.	5	$97
Merck	4	$79
Sanofi Pasteur Inc.	4	$68
Corium, LLC	3	$57
Pfizer	3	$56
Seqirus USA Inc	3	$56
Takeda Pharmaceuticals U.S.A., Inc.	3	$48
Collegium Pharmaceutical, Inc.	1	$21
Neos Therapeutics, LP	1	$18
Hologic Sales And Service, LLC	1	$17
Genentech USA, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,155 in reported general payments places this provider in the 90th percentile of 913 pediatrics providers in Louisiana.

See all pediatrics providers in Louisiana →

Other pediatrics in Bogalusa

Katie QueenBogalusa$61K
Corey HebertGretna$1.3M
Elizabeth WhiteCovington$19K
Neslihan GungorShreveport$16K
Amy VitteLafayette$10K
Alicia NicklasLafayette$9K
Paul YuratichNew Orleans$9K
Catherine SpillerWalker$8K
Mamatha MandavaShreveport$8K
Caroline KlineBaton Rouge$8K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →